P0517: Role of radiomics in predicting the degree of intestinal fibrosis in patients with Crohn's DiseaseECCO'25Year: 2025
Authors: Laterza, L.(1);Maresca, R.(1)*;Varca, S.(1);Tran, H.E.(2);Boccia, E.(2);Larosa, L.(2);Sessa, G.M.(1);Mignini, I.(1);Sacchetti, F.(3);Giustiniani, M.C.(4);Boldrini, L.(2);Sofo, L.(3);Minordi, L.M.(2);Cammarota, G.(5);Papa, A.(1);Gasbarrini, A.(1);Scaldaferri, F.(1);
(1)UOS Malattie Infiammatorie Croniche Intestinali- Centro Malattie Apparato Digerente CeMAD-Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS- Università Cattolica del Sacro Cuore, Rome, Italy;(2)Department of Diagnostic Imaging- Oncological Radiotherapy- and Hematology, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy;(3)Division of General Surgery, Catholic University of the Sacred Heart, Rome, Italy;(4)Facoltà di Medicina e Chirurgia- Università Cattolica del Sacro Cuore- Rome- Italy- Istituto di Anatomia Patologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;(5)Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuor, Rome, Italy;
P0518: Study of the prevalence of defecatory disorders in patients with quiescent ulcerative colitis using high resolution anorectal manometryECCO'25Year: 2025
Authors: Abdelaty, K.(1)*;
(1)Alexandria Unversiaty, Internal medicine-gastroenterology unit, Alex, Egypt; Hussein Saad Eman Abu El-Soud Ezzat Ali
Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019; 65:100-51.
Kang HR, Lee JE, Lee JS, Lee TH, Hong SJ, Kim JO, et al. Comparison of high-resolution anorectal manometry with water-perfused anorectal manometry. J Neurogastroenterol Motil. 2015; 21:126-32.
Torresan F, Mandolesi D, Bonventre S, Usai P. Differences between conventional anorectal manometry and high resolution\high-definition anorectal manometry. In: Bellini M, editor. High resolution and high-definition anorectal manometry. 5. Cham: Springer; 2020. p.49-68.
P0519: Upadacitinib in Acute Severe Ulcerative Colitis among previously anti-TNFa exposed patients.ECCO'25Year: 2025
Authors: Manti, M.(1)*;Kamperidis, N.(1);Toskas, A.(1);Misra, R.(1);Arebi, N.(1);
(1)St Mark's Hospital, Gastroenterology, London, United Kingdom;
1.Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384-413. doi:10.14309/ajg.0000000000000152
2.Berinstein JA, Karl T, Patel A, et al. Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience. Am J Gastroenterol. 2024;119(7):1421-1425. doi:10.14309/ajg.0000000000002674
3.Ali NM, Shehab MA. Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature. Am J Case Rep. 2023;24. doi:10.12659/AJCR.940966
P0520: Association between interoception and Visceral Hypervigilance in patients with Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Knödler, L.L.(1)*;Rösch, T.(1);Atanasova, K.(1);Ebert, M.(1);Thomann, A.(1);Reindl, W.(1);
(1)Medical Faculty Mannheim - Heidelberg University, Department of Medicine II, Mannheim, Germany;
1 Thomann AK, Knödler LL, Karthikeyan S, et al. The Interplay of Biopsychosocial Factors and Quality of Life in Inflammatory Bowel Diseases: A Network Analysis. J Clin Gastroenterol. 2023;57(1):57-65. Published 2023 Jan 1. doi:10.1097/MCG.0000000000001625
2 Herbert BM, Muth ER, Pollatos O, Herbert C. Interoception across modalities: on the relationship between cardiac awareness and the sensitivity for gastric functions. PLoS One. 2012;7(5):e36646. doi:10.1371/journal.pone.0036646
3 Whitehead WE, Drescher VM. Perception of gastric contractions and self-control of gastric motility. Psychophysiology. 1980;17(6):552-558. doi:10.1111/j.1469-8986.1980.tb02296.x
P0521: Accuracy of a non-invasive approach in monitoring pediatric inflammatory bowel disease: interim-analysis of a prospective multicenter italian studyECCO'25Year: 2025
Authors: D'Arcangelo, G.(1)*;Gravina, A.(1);Colucci, A.(2);Raso, T.(1);Casertano, M.(2);Cenni, S.(2);Strisciuglio, C.(2);Maccioni, F.(3);Oliva, S.(1);
(1)Sapienza University of Rome, Maternal and Child Health Department, Rome, Italy;(2)University of Campania "Luigi Vanvitelli", Department of Woman- Child and General and Specialistic Surgery, Naples, Italy;(3)Sapienza University of Rome, Department of Radiological- Oncology and Patological Sciences, Rome, Italy;
P0522: Transmural healing rate does not differ between Crohn's disease patients with structural damage versus inflammatory behaviorECCO'25Year: 2025
Authors: Marques Garcia, P.(1)*;Albert Palomares , S.(1);Fquihi Chetouani, M.(1);Torrente Sánchez, J.(1); Pérez Ibáñez, A.A.(1);Rabadán Mata, A.(1);Peiró García, E.(1);Blanc Garcia, E.(2);Martinez Perez, M.J.(2);Paredes Arquiola, J.M.(1);
(1)Hospital Doctor Peset, Department of Digestive Medicine, Valencia, Spain;(2)Hospital Doctor Peset, Department of Diagnostic Radiology, Valencia, Spain; Transmural healing rate does not differ between crohn's disease patients with structural damage versus inflammatory behavior
1.Wilkens R, Novak KL, Maaser C, et al. Relevance of monitoring transmural disease activity in patients with Crohn's disease: current status and future perspectives. TherapAdvGastroenterol. 2021. doi: 10.1177/17562848211006672.
2.Paredes JM, Moreno N, Latorre P, et al. Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease. Dig Dis Sci. 2019;64:2600-2606.
3.Muñoz F, Ripollés T, Poza Cordón J, et al. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease. GastroenterolHepatol. 2021;44:158-174.
4.Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study. ClinGastroenterolHepatol. 2022;20:711-722.
5.Fraquelli M, Castiglione F, Calabrese E, et al. Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice. Dig Liver Dis. 2020;52:9-18.
6.Fiorino G, Bonifacio C, Allocca M, et al. Impact of therapies on bowel damage in Crohn's disease. United European Gastroenterol J. 2020;8:410-417.
P0523: Comparative analysis of two ELISA methods for measuring serum ustekinumab levels in Inflammatory Bowel Disease ¿Is interchangeability feasible?ECCO'25Year: 2025
Authors: Dueñas-Prieto, L.(1);Cabrera-Marante, Ó.(1);Algara, M.(2);Alfocea-Molina, Á.(1);Rafael de la Cruz, D.(2);Garcinuño, S.(3);Masedo, Á.(2);Yela, C.(2);López, F.(2);Olmedo, C.(2);Casis, B.(2);Gonzalez LamaMD- PhD, Y.(2)*;
(1)Hospital Universitario 12 de Octubre, Immunology Department, Madrid, Spain;(2)Hospital Universitario 12 de Octubre, Digestive Medicine Department. Gastroenterology Section. IBD Unit., Madrid, Spain;(3)Hospital Universitario 12 de Octubre, Research Institute imas12, Madrid, Spain;
- Kwon Y, Kang B, Kim ES, Choe YH, Kim MJ. Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease. Ther Drug Monit. 2022;44(4):535-542. doi:10.1097/FTD.0000000000000976
- Rodríguez-Moranta F, Argüelles-Arias F, Hinojosa Del Val J, et al. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU). Gastroenterol Hepatol. 2024;47(5):522-552. doi:10.1016/j.gastrohep.2024.01.007
P0524: Advanced therapy options, choice, access, and treatment empowerment for Inflammatory Bowel Disease (ADVOCATE-IBD): A UK-wide qualitative studyECCO'25Year: 2025
Authors: Hardasani, R.(1)*;Radford, S.(2);Peerally, M.(3);
(1)University of Leicester, Medical School, Leicester, United Kingdom;(2)The University of Nottingham- School of Medicine, Nottingham NIHR Biomedical Research Centre- Liver and GI Disorders, Nottingham, United Kingdom;(3)University of Leicester, Department of Population Health Sciences- SAPPHIRE, Leicester, United Kingdom;
1. Jairath V, Feagan BG. Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020;5(1):2–3. Accessed Apr 15, 2024. doi: 10.1016/S2468-1253(19)30358-9.
2. Lofland JH, Johnson PT, Ingham MP, Rosemas SC, White JC, Ellis L. Shared decision-making for biologic treatment of autoimmune disease: Influence on adherence, persistence, satisfaction, and health care costs. Patient Preference and Adherence. 2017;11:947–958. https://www.tandfonline.com/doi/abs/10.2147/PPA.S133222. Accessed Dec 31, 2023. doi: 10.2147/PPA.S133222.
3. Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022;292:114523. Accessed Nov 5, 2023. doi: 10.1016/j.socscimed.2021.114523.
4. Green J, Thorogood N. Qualitative methods for health research / judith green, nickithorogood. 4th ed. London: SAGE Publications Ltd; 2018:17. http://digital.casalini.it/9781526448804.
P0525: Genome-wild gene expression analysis and identification of Crohn's disease from intestinal tuberculosis and primary intestinal lymphomaECCO'25Year: 2025
Authors: Lin, L.(1);Wang, Y.(1)*;Zhao, X.(1);
(1)Nanfang Hospital- Southern Medical University, Department of Gastroenterology, Guangzhou, China;
[1]TORRES J, MEHANDRU S, COLOMBEL J F, et al. Crohn's disease [J]. Lancet (London, England), 2017, 389(10080): 1741-55.
[2]PEREZ E J, CEPERO M L, PEREZ S U, et al. EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain [J]. Neurobiology of disease, 2016, 94: 73-84.
[3]THEUS M H, RICARD J, GLASS S J, et al. EphrinB3 blocks EphB3 dependence receptor functions to prevent cell death following traumatic brain injury [J]. Cell death & disease, 2014, 5(5): e1207.
[4]CHIU S T, CHANG K J, TING C H, et al. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells [J]. Carcinogenesis, 2009, 30(9): 1475-86.
P0526: Association of plasma IgA with bowel wall thickness and disease activity in IBD patients assessed by intestinal ultrasoundECCO'25Year: 2025
Authors: Chen, Y.L.(1)*;Tsai, T.(1,2,3);
(1)China Medical University Hospital, Center for Digestive Medicine, Taichung, Taiwan;(2)National Health Research Institutes, Immunology Research Center, Zhunan, Taiwan;(3)China Medical University, School of Medicine, Taichung, Taiwan;
1. B Lee, J Hsu, T Tsai, A241 Correlation between plasma IgA level and biological therapy in inflammatory bowel disease, Journal of the Canadian Association of Gastroenterology, 2024;doi.org/10.1093/jcag/gwad061.241
P0527: Bowel Ultrasound Scan (BUS) in Pediatric Acute Severe Colitis (ASC): a multicenter prospective study on behalf of the IBD Porto groupECCO'25Year: 2025
Authors: Scarallo, L.(1)*;Alvisi, P.(2);Aloi, M.(3);Bramuzzo, M.(4);Broekaert, I.(5);De Laffolie, J.(6);Kierkus, J.(7);Matar, M.(8);Pranzetti, A.(9);Renzo, S.(1);Velasco Rodríguez-Belvís, M.(10);Strisciuglio, C.(11);Tasciotti, L.(12);Lionetti, P.(1);
(1)Meyer Children's Hospital IRCCS, Gastroenterology and Nutrition Unit, Florence, Italy;(2)Maggiore "CA Pizzardi" Hospital- Bologna- Italy, Pediatric Gastroenterology Unit-, Bologna, Italy;(3)Sapienza University of Rome- Umberto I Hospital- Rome- Italy., Pediatric Gastroenterology and Hepatology Unit-, Rome, Italy;(4)IRCCS "Burlo Garofolo", Institute for Maternal and Child Health, Trieste, Italy;(5)Faculty of Medicine and University Hospital Cologne- University of Cologne- Cologne- Germany, Department of Paediatrics, Cologne, Germany;(6)Justus-Liebig-University Giessen- Childrens Hospital, Pediatric Gastroenterology, Giessen, Italy;(7)The Children's Memorial Health Institute- 04-730 Warsaw- Poland, Department of Gastroenterology- Hepatology- Feeding Disorders and Pediatrics-, Warsaw, Poland;(8)Schneider Children's Medical Centre- Petach-Tikva- Israel, Institute of Gastroenterology- Nutrition and Liver Diseases, Petach-Tikva, Israel;(9)Maggiore "CA Pizzardi" Hospital- Bologna- Italy., Pediatric Gastroenterology Unit, Bologna, Italy;(10)Hospital Infantil Universitario Niño Jesús- Madrid- Spain, Sección de Gastroenterología y Nutrición Pediátrica-, Madrid, Spain;(11)University of Campania "Luigi Vanvitelli"- Naples- Italy, Department of Woman- Child and General and Specialist Surgery, Naples, Italy;(12)Meyer Children's Hospital IRCCS, Radiology Unit, Florence, Italy; IBD Porto Group
P0528: Leukocyte Adhesive Function as Potential Predictive Marker for Treatment Response to Vedolizumab Among Bio-naive Patients with Crohn’s DiseaseECCO'25Year: 2025
Authors: Liu, J.(1,2)*;Cheng, Q.(3);Cao, Q.(1,2);
(1)Sir Run Run Shaw Hospital- Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China;(2)Sir Run Run Shaw Hospital- Zhejiang University School of Medicine, Inflammatory Bowel Disease Center, Hangzhou, China;(3)StickyCell Biotech Shanghai Ltd, StickyCell Biotech Shanghai Ltd, Shanghai, China;
Dulai PS, Boland BS, Singh S, et al. Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease. Gastroenterology. 2018;155(3):687-695.e10. doi:10.1053/j.gastro.2018.05.039
P0530: Relationships and sexuality in patients with inflammatory bowel disease – The perspective of healthcare professionalsECCO'25Year: 2025
Authors: Jäghult, S.(1)*;Druvefors, E.(2);Bello, F.(3);Florwald, E.(4);Forsell, A.(5);Myrelid, P.(6);Almer, S.(3);
(1)Karolinska Institutet, Department of clinical science and education, Stockholm, Sweden;(2)Länssjukhuset Ryhov, Länssjukhuset Ryhov, Jönköping, Sweden;(3)Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden;(4)Karolinska Institutet, Ersta sjukhus, Stockholm, Sweden;(5)Ersta Hospital, Ersta Hospital, Stockholm, Sweden;(6)Linköping University Hospital, Linköping University Hospital, Linköpig, Sweden;
P0532: Exploring biomarkers of systemic oxidative stress and placental insufficiency in pregnant women with Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Holstein, H.J.(1);Bouwknegt, D.G.(1);Visschedijk, M.C.(1);Bulthuis, M.L.C.(2);Reinders-Luinge, M.(2);Schoots, M.H.(3);van Goor, H.(2);Gordijn, S.J.(3);Dijkstra, G.(1);Bourgonje, A.R.(1,4)*;
(1)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(2)University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands;(3)University Medical Center Groningen, Department of Obstetrics and Gynecology, Groningen, The Netherlands;(4)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;
P0533: Extremely Rare Case of Isolated Colonic Inflammatory Cap Polyps in a Patient with Known Long-Standing Ulcerative ColitisECCO'25Year: 2025
Authors: Pellegrino, R.(1);Palladino, G.(1);De Costanzo, I.(1);Izzo, M.(1);Imperio, G.(1);Landa, F.(1);Federico, A.(1);Gravina, A.G.(1)*;
(1)University of Campania Luigi Vanvitelli, Department of Precision Medicine, Naples, Italy;
Mason M, Faizi SA, Fischer E, Rajput A. Inflammatory cap polyposis in a 42-year-old male. Int J Surg Case Rep. 2013;4(3):351-353. doi:10.1016/j.ijscr.2012.12.0142.
Batra S, Johal J, Lee P, Hourigan S. Cap Polyposis Masquerading as Inflammatory Bowel Disease in a Child. J Pediatr Gastroenterol Nutr. 2018;67(3):e57. doi:10.1097/MPG.00000000000013433. Valdés Delgado T, Barranco Castro D,
Argüelles Arias F. Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis. Inflamm Bowel Dis. 2022;28(7):e108-e109. doi:10.1093/ibd/izac023
P0534: School-related challenges in paediatric Inflammatory Bowel Diseases and the role of patient associations: results from a national survey of over 350 italian paediatric patientsECCO'25Year: 2025
Authors: Gianolio, L.(1)*;Silvera, V.(1);Quaglia, M.(2);Brazzoduro, V.(2);Penagini, F.(2);Dilillo, D.(2);Previtali, E.(3);Leone, S.(3);Zuccotti, G.V.(1,4);Norsa, L.(2);
(1)Buzzi Children's Hospital University of Milan, Department of Paediatrics, Milan, Italy;(2)Buzzi Children's Hospital, Department of Paediatrics, Milan, Italy;(3)AMICI Italia Onlus, Associazione Nazionale per le Malattie Infiammatorie Croniche dell’Intestino, Milan, Italy;(4)University of Milan, Department of Biomedical and Clinical Sciences, Milan, Italy;
1.Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. doi:10.1053/j.gastro.2020.12.031
2. Freckmann M, Seipp A, Laass MW, et al. School-related experience and performance with inflammatory bowel disease: results from a cross-sectional survey in 675 children and their parents. BMJ Open Gastroenterol. 2018;5(1):e000236. doi:10.1136/bmjgast-2018-000236
P0535: Crohn’s Anal Fistula - Quality of Life (CAFQOL) for disease control and remission in patients with perianal fistulizing Crohn’s disease: a new standard in assessing clinical outcome?ECCO'25Year: 2025
Authors: Mulders, L.(1)*;Beek, K.(2);Tielbeek, J.(3);Zwart, M.(1);Rietdijk, S.(4);Jansen, J.(4);Stoker, J.(2);Buskens, C.(5);D'Haens, G.(1);Gecse, K.(1);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC, Department of Radiology and Nuclear Medicine, Amsterdam, The Netherlands;(3)Spaarne Gasthuis, Department of Radiology and Nuclear Medicine, Haarlem, The Netherlands;(4)OLVG, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(5)Amsterdam UMC, Department of Surgery, Amsterdam, The Netherlands; AMFIBIO study group
P0536: Clinical profile and treatment outcomes in patients receiving advanced therapies for ulcerative colitis – the READ-UC real-world studyECCO'25Year: 2025
Authors: Fernandes, S.R.(1)*;Tavares de Sousa, H.(2);Portela, F.(3);Ministro, P.(4);Lago, P.(5);Branquinho, D.(6);Freitas, I.(7);Martins Machado, N.(7);Magro, F.(8);
(1)Unidade Local de Saúde de Santa Maria, Serviço de Gastrenterologia e Hepatologia, Lisbon, Portugal;(2)Unidade Local de Saúde do Algarve, Serviço de Gastrenterologia, Portimão, Portugal;(3)Unidade Local de Saúde de Coimbra, Serviço de Gastrenterologia, Coimbra, Portugal;(4)Unidade Local de Saúde de Viseu Dão-Lafões, Serviço de Gastrenterologia, Viseu, Portugal;(5)Unidade Local de Saúde de Santo António, Serviço de Gastrenterologia, Porto, Portugal;(6)Pfizer Inc, Medical Affairs, New York, United States;(7)Laboratórios Pfizer Lda, Medical Affairs, Porto Salvo, Portugal;(8)Unidade Local de Saúde de São João, Serviço de Gastrenterologia, Porto, Portugal;
P0537: Prognostic significance of anastomotic lesions in post-operative Crohn's diseaseECCO'25Year: 2025
Authors: Del Gaudio, A.(1)*;Cuccia, G.(1);Privitera, G.(2);Parisio , L.(3);Coppola, G.(3);Laterza, L.(3);Lopetuso, L.R.(3);Carbone, L.(4);Papa, A.(1);Cammarota, G.(1);Gasbarrini, A.(1);Scaldaferri, F.(3);Pugliese, D.(5);
(1)Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica, Roma, Italy;(2)Humanitas University, UOS Malattie Infiammatorie Croniche Intestinali, Milano, Italy;(3)Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOS Malattie Infiammatorie Croniche Intestinali - Centro Malattie Apparato Digerente CEMAD, Roma, Italy;(4)Ospedale Isola Tiberina Gemelli Isola, UOC Pronto Soccorso- Medicina d'Urgenza e Medicina Interna, Roma, Italy;(5)Ospedale Isola Tiberina Gemelli Isola, UOS Gastroenterologia, Roma, Italy;
1) De Cruz P, Hamilton AL, Burrell KJ, Gorelik A, Liew D, Kamm MA. Endoscopic Prediction of Crohn's Disease Postoperative Recurrence. Inflamm Bowel Dis. 2022 May 4;28(5):680-688. doi: 10.1093/ibd/izab134. PMID: 34231852.2)
2) Ueda T, Koyama F, Sugita A, Ikeuchi H, Futami K, Fukushima K, Nezu R, Iijima H, Mizushima T, Itabashi M, Watanabe K, Hata K, Shinagawa T, Matsuoka K, Takenaka K, Sasaki M, Nagayama M, Yamamoto H, Shinozaki M, Fujiya M, Kato J, Ueno Y, Tanaka S, Okita Y, Hashimoto Y, Kobayashi T, Koganei K, Uchino M, Fujii H, Suzuki Y, Hisamatsu T. Endoscopic Lesions of Postoperative Anastomotic Area in Patients With Crohn's Disease in the Biologic Era: A Japanese Multi-Centre Nationwide Cohort Study. J Crohns Colitis. 2023 Dec 30;17(12):1968-1979. doi: 10.1093/ecco-jcc/jjad116. PMID: 37450892.
P0538: Histologic remission predicts relapse in patients with Ulcerative ColitisECCO'25Year: 2025
Authors: Lopes, S.(1)*;Teixeira, M.(1);Tomás, D.(1);Sequeira, C.(1);Teixeira, C.(1);Gamito, É.(1);Alves, A.L.(1);
(1)Unidade Local Saúde Arrábida, Gastroenterology, Setúbal, Portugal;
Lobatón T, Bessissow T, Ruiz-Cerulla A, De Hertogh G, Bisschops R, Guardiola J, Van Assche G, Vermeire S, Ferrante M. Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study. United European Gastroenterol J. 2018 Jun;6(5):765-772. doi: 10.1177/2050640617752207.
